AAAAI 2021: Tezepelumab Effective for Uncontrolled Asthma Regardless of Baseline Eosinophil Count
This is the first biologic shown to reduce exacerbations in severe asthma regardless of baseline eosinophil count
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.